Related Experiment Video
Updated: Jan 19, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Tumor grading of soft tissue sarcomas using MRI-based radiomics
Jan C Peeken1, Matthew B Spraker2, Carolin Knebel3
1Department of Radiation Oncology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich (TUM), Ismaninger Straße 22, 81675 Munich, Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Germany.
MRI radiomics models accurately differentiate low-grade from high-grade soft tissue sarcomas (STS). These models improve prognostic performance when combined with clinical staging, aiding treatment decisions for STS patients.
Area of Science:
- Radiology
- Oncology
- Medical Imaging Analysis
Background:
- Accurate grading of soft tissue sarcoma (STS) is crucial for treatment decisions.
- Differentiating low-grade (G1) from high-grade (G2/G3) STS impacts multimodal therapy planning.
- MRI-based radiomics offers a potential non-invasive method for STS grading.
Purpose of the Study:
- To develop and validate MRI-based radiomics models for differentiating low-grade and high-grade STS.
- To assess the performance of radiomics models using different MRI sequences (T2FS, T1FSGd).
- To evaluate the added value of radiomics models combined with clinical staging for prognosis.
Main Methods:
- Retrospective analysis of two independent STS patient cohorts.
- Extraction of 1394 radiomics features from T2FS and T1FSGd MRI sequences.
- Development of Least Absolute Shrinkage and Selection Operator (LASSO) models using nested cross-validation.
- Assessment of ComBat Harmonization for batch effect correction.
Main Results:
- Radiomics models achieved AUCs of 0.78 (T2FS), 0.69 (T1FSGd), and 0.76 (combined) on the validation set.
- The T2FS-based model demonstrated superior reproducibility.
- Integration of the T2FS radiomics model with clinical staging improved prognostic performance and clinical net benefit.
Conclusions:
- MRI-based radiomics tumor grading models effectively classify low-grade and high-grade soft tissue sarcomas.
- These models can aid in patient stratification and improve prognostic accuracy.
- Radiomics analysis holds promise for non-invasive grading of STS.
Related Concept Videos
07:55Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:15A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
04:11DCE-MRI of Orthotopic Pancreatic Tumor Xenografts: A Method to Assess Microvasculature in a Target Tumor Tissue
07:18Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
04:37Sampling Prostate Cancer Tissue for Biobanking: An MRI-guided Targeted Technique to Remove Biopsy Punches from Fresh Tumor Tissue
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

